Wenzhou Ding
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Circular RNAs in diseases 5
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Yongping Zhou (8 shared papers)Zhiyuan Hua (2 shared papers)Sijin Cheng (1 shared paper)Junsheng Fan (1 shared paper)Guoyong Han (8 shared papers)Qingfeng Ni (3 shared papers)Jindao Wu (5 shared papers)Lianbao Kong (8 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Medicine (1 paper)Cancer Cell International (1 paper)PLoS ONE (1 paper)Experimental Hematology and Oncology (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Wenzhou Ding
18 papers receiving 412 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 160
- Oncology 120
- Immunology 56
- Molecular Biology 160
- Hepatology 13
Countries citing papers authored by Wenzhou Ding
This map shows the geographic impact of Wenzhou Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzhou Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzhou Ding more than expected).
Fields of papers citing papers by Wenzhou Ding
This network shows the impact of papers produced by Wenzhou Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzhou Ding. The network helps show where Wenzhou Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenzhou Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 114 | |
| 2 | 2014 | 82 | |
| 3 | 2023 | 58 | |
| 4 | 2017 | 54 | |
| 5 | 2016 | 30 | |
| 6 | 2014 | 20 | |
| 7 | 2015 | 11 | |
| 8 | 2021 | 10 | |
| 9 | 2018 | 7 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2024 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Wenzhou Ding
Wenzhou Ding is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Cell Biology, having authored 24 papers that have together received 415 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Gaze Tracking and Assistive Technology (2 papers). The work is most often cited by research in Cancer Research (160 citations), Oncology (120 citations), Immunology (56 citations), Molecular Biology (160 citations) and Hepatology (13 citations). Wenzhou Ding has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Yongping Zhou, Zhiyuan Hua, Sijin Cheng, Junsheng Fan, Guoyong Han, Qingfeng Ni, Jindao Wu, Lianbao Kong, Liangliang Kong and Weibing Tang. Their work appears in journals such as Frontiers in Oncology, Medicine, Cancer Cell International, PLoS ONE and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.